Expressing support for testing for antiphospholipid syndrome (APS) as a standard part of prenatal screening, and for other purposes.

Hozzl · 2025-09-27T08:06:01Z

Explore the details of House Bill 685 Expressing support for testing for antiphospholipid syndrome (APS) as a standard part of prenatal screening, and for other purposes. currently in Congress. Get insights into its purpose, current status, sponsors, and potential impact on Health. Stay informed on legislative developments.

9/27/2025, 8:06 AM

Summary of Bill HRES 685

The bill "Expressing support for testing for antiphospholipid syndrome (APS) as a standard part of prenatal screening" was introduced in the 119th Congress as H.Res. 685 on September 9, 2025. This resolution aims to advocate for the inclusion of testing for APS in prenatal screenings. The bill emphasizes supporting this specific medical testing as part of routine prenatal care, with a focus on early detection and potential intervention. For further details, the official PDF version of the bill can be accessed at https://www.congress.gov/119/bills/hres685/BILLS-119hres685ih.pdf.

Read the Full Bill

Formatted Text PDF Formatted XML

Current Status of Bill HRES 685

Bill HRES 685 is currently in the status of Bill Introduced since September 9, 2025. Bill HRES 685 was introduced during Congress 119 and was introduced to the House on September 9, 2025. Bill HRES 685's most recent activity was Referred to the House Committee on Energy and Commerce. as of September 9, 2025